{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifenqtrcetwjoexvupkrbxug4p2trkz6hj3rxiu45tgoelu4pwyy4",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mk3s36md6iw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibkahdwafg6nvppny6qifl5etz33pah2kpwjskruj6hftboaxlhtu"
    },
    "mimeType": "image/jpeg",
    "size": 166086
  },
  "path": "/news/2026-04-ibs-treatment-response-gut-microbiome.html",
  "publishedAt": "2026-04-22T10:20:07.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "In a new study published in Clinical Gastroenterology and Hepatology, the low FODMAP diet and the antibiotic rifaximin provided similar and significant relief for patients with irritable bowel syndrome with diarrhea (IBS-D).",
  "title": "IBS treatment response predicted by gut microbiome in new study"
}